Nigral endothelial dysfunction, homocysteine, and Parkinson's disease
- 1 July 1999
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 354 (9173) , 126-127
- https://doi.org/10.1016/s0140-6736(99)01660-8
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Blood vessels change in the mesencephalon of patients with Parkinson's diseasePublished by Elsevier ,1999
- Elevated Plasma Levels of Homocysteine inParkinson’s DiseaseEuropean Neurology, 1998
- Acute hyperhomocysteinaemia and endothelial dysfunctionThe Lancet, 1998
- Effect of L-Dopa and the Catechol-O-Methyltransferase Inhibitor Ro 41–0960 on Sulfur Amino Acid Metabolites in RatsClinical Neuropharmacology, 1997
- Survival and cause of death in a cohort of patients with parkinsonism: possible clues to aetiology?Journal of Neurology, Neurosurgery & Psychiatry, 1995